Theranexus Société Anonyme (ALTHX.PA)
- Previous Close
0.6580 - Open
0.6800 - Bid --
- Ask --
- Day's Range
0.5800 - 0.7160 - 52 Week Range
0.2605 - 1.2000 - Volume
218,059 - Avg. Volume
40,688 - Market Cap (intraday)
5.343M - Beta (5Y Monthly) 1.72
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1700 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.90
Theranexus Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was founded in 2013 and is headquartered in Lyon, France.
www.theranexus.comRecent News: ALTHX.PA
View More
Performance Overview: ALTHX.PA
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALTHX.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALTHX.PA
View MoreValuation Measures
Market Cap
5.32M
Enterprise Value
6.50M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-76.87%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
2.3M
Net Income Avi to Common (ttm)
-1.76M
Diluted EPS (ttm)
-0.1700
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--